Literature DB >> 25973016

Two novel mutations in NOTCH3 gene causes cerebral autosomal dominant arteriopathy with subcritical infarct and leucoencephalopathy in two Chinese families.

Yuyou Zhu1, Juan Wang2, Yuanbo Wu1, Guoping Wang1, Bai Hu2.   

Abstract

OBJECTIVE: To investigate the genetic pathogenic causes of cerebral autosomal dominant arteriopathy with subcritical infarct and leucoencephalopathy (CADASIL) in two Chinese families, to provide the molecular basis for genetic counseling and antenatal diagnosis.
METHODS: The genetic mutation of gene NOTCH3 of propositus and family members was analyzed in these two CADASIL families by polymerase chain reaction and DNA sequencing technology directly. At the same time, the NOTCH3 gene mutation point of 100 healthy collators was detected, to explicit the pathogenic mutation by function prediction with Polyphen-2 and SIFT.
RESULTS: Both propositus of the two families and patients with symptom were all accorded with the clinical features of CADASIL. It was shown by DNA sequencing that the 19(th) exon [c. 3043 T > A (p.Cys1015Ser)] in gene NOTCH3 of propositus, 2 patients (II3, III7), and a presymptomatic patient (IV1) in Family I all had heterozygosity missense mutation; and the 3(rd) exon [c.316T > G, p. (Cys106Gly)] in gene NOTCH3 of the propositus, a patient (IV3) and two presymptomatic patients (IV5, 6) in Family II all had heterozygosity missense mutation; and no mutations were detected in the 100 healthy collators. It was indicated by analyzing the function prediction that the mutation of [c. 3043 T > A (p.Cys1015Ser)] and [c.316T > G, p. (Cys106Gly)] may both influence encoding protein in NOTCH3. By analysis of the conservatism of mutation point in each species, these two basic groups were highly conserved.
CONCLUSION: The heterozygosity missense mutation of 19(th) exon [c. 3043 T > A (p.Cys1015Ser)] and the 3(rd) exon [c.316T > G, p. (Cys106Gly)] in NOTCH3 gene are the new pathogenic mutations of CADASIL, and enriches the mutation spectrum of NOTCH3 gene.

Entities:  

Keywords:  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoeneephalopathy; NOTCH3 gene; mutation

Mesh:

Substances:

Year:  2015        PMID: 25973016      PMCID: PMC4396336     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  11 in total

1.  Mutational and haplotype map of NOTCH3 in a cohort of Italian patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Authors:  S Testi; G Malerba; M Ferrarini; M Ragno; L Pradotto; A Mauro; G M Fabrizi
Journal:  J Neurol Sci       Date:  2012-06-03       Impact factor: 3.181

2.  Parkinsonism is a late, not rare, feature of CADASIL: a study on Italian patients carrying the R1006C mutation.

Authors:  Michele Ragno; Alfonso Berbellini; Gabriella Cacchiò; Antonio Manca; Fabio Di Marzio; Luigi Pianese; Anna De Rosa; Serena Silvestri; Maria Scarcella; Giuseppe De Michele
Journal:  Stroke       Date:  2013-02-14       Impact factor: 7.914

3.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy affecting an African American man: identification of a novel 15-base pair NOTCH3 duplication.

Authors:  Soo Jung Lee; He Meng; Omar Elmadhoun; Mila Blaivas; Michael Mei-Hwa Wang
Journal:  Arch Neurol       Date:  2011-12

4.  NOTCH3 mutations and clinical features in 33 mainland Chinese families with CADASIL.

Authors:  Zhaoxia Wang; Yun Yuan; Wei Zhang; He Lv; Daojun Hong; Bin Chen; Yang Liu; Xinghua Luan; Sheng Xie; Shiwen Wu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-09       Impact factor: 10.154

5.  Glial vascular degeneration in CADASIL.

Authors:  Thea Brennan-Krohn; Stephen Salloway; Stephen Correia; Matthew Dong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Neuropathological correlates of temporal pole white matter hyperintensities in CADASIL.

Authors:  Yumi Yamamoto; Masafumi Ihara; Carina Tham; Roger W C Low; Janet Y Slade; Tim Moss; Arthur E Oakley; Tuomo Polvikoski; Raj N Kalaria
Journal:  Stroke       Date:  2009-04-09       Impact factor: 7.914

7.  Activating NOTCH3 mutation in a patient with small-vessel-disease of the brain.

Authors:  Charles Fouillade; Hugues Chabriat; Florence Riant; Manuèle Mine; Minh Arnoud; Laurent Magy; Marie Germaine Bousser; Elisabeth Tournier-Lasserve; Anne Joutel
Journal:  Hum Mutat       Date:  2008-03       Impact factor: 4.878

8.  High recurrence of the R1006C NOTCH3 mutation in central Italian patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Authors:  Alessia Cappelli; Michele Ragno; Gabriella Cacchiò; Maria Scarcella; Paolo Staffolani; Luigi Pianese
Journal:  Neurosci Lett       Date:  2009-07-02       Impact factor: 3.046

9.  Population-specific spectrum of NOTCH3 mutations, MRI features and founder effect of CADASIL in Chinese.

Authors:  Yi-Chung Lee; Chin-San Liu; Ming-Hong Chang; Kon-Ping Lin; Jong-Ling Fuh; Yi-Chu Lu; Ya-Fen Liu; Bing-Wen Soong
Journal:  J Neurol       Date:  2009-02-26       Impact factor: 4.849

10.  "CADASIL coma" in an Italian homozygous CADASIL patient: comparison with clinical and MRI findings in age-matched heterozygous patients with the same G528C NOTCH3 mutation.

Authors:  Michele Ragno; Luigi Pianese; Manrico Morroni; Gabriella Cacchiò; Antonio Manca; Fabio Di Marzio; Serena Silvestri; Cristina Miceli; Maria Scarcella; Marco Onofrj; Luigi Trojano
Journal:  Neurol Sci       Date:  2013-04-10       Impact factor: 3.307

View more
  2 in total

1.  A novel cysteine-sparing G73A mutation of NOTCH3 in a Chinese CADASIL family.

Authors:  Liyan Huang; Wei Li; Yi Li; Chaoyuan Song; Pin Wang; Hongchun Wang; Xiulian Sun
Journal:  Neurogenetics       Date:  2019-11-13       Impact factor: 2.660

2.  Association of Notch3 single-nucleotide polymorphisms and lacunar infarctions in patients.

Authors:  Ying Li; Nan Liu; Hui Chen; Yonghua Huang; Weiwei Zhang
Journal:  Exp Ther Med       Date:  2015-11-26       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.